First though, since resistance that is acquired through mutation of the drug target still remains one of the most serious causes of the failure of cancer chemotherapy, we consider whether an appreciable resistance to N-domain inhibitors could arise by the mutation, or altered modification, of Hsp90 itself. The gene discussed is HSP90AB1; the disease is cancer.